Not all startups are on a unicorn trajectory. Investors who fund Series A, Series B, and Series C companies can find their portfolios over leveraged with no success in sight. Stage knows how to help, saving you time and money.
We understand that portfolio restructuring can be part of your job as a venture capital investor. At times, selling previous investments can be a piece of this process for Series A, Series B, and Series C investors. Venture lenders similarly need help with startups who may not be able to raise their next round and pay back their venture debt.
Stage Fund helps you free up resources so that you can focus on the top 3% in your portfolio by filtering through the companies that might be of interest to the Stage model. When your portfolio becomes over leveraged, the Stage Fund team is here to help. We have unrivaled experience in buyouts, acquisitions, restructuring, and turnarounds and have seen it all. Stage can work with you and the company to find a solution that benefits everyone.
Raising the next round – Series A, Series B, or Series C – is not possible for many startups. We identify companies with these special situations and acquire a controlling interest in early-stage companies. We pair our bespoke shared services and studio model with the company’s needs in order to find an efficient exit.
Stage Fund is industry agnostic (no life science or bio-tech) and focuses on acquiring Series A, Series B, and Series C B2B companies with a high-tech or consumer product. The portfolio companies we acquire have $2-$10MM in revenue, but need a path forward outside of traditional venture capital.
Let's talk about some of our previous exits and how we built bespoke shared services to get them on a track to profitability.
Stage is industry agnostic
(no life science or bio-tech)
B2B companies with a high-tech or consumer product.
$2-$10MM in revenue